CBD: 6 myths you should know about

Expert Talk | 0 comments

Common beliefs that aren’t entirely true

We have all seen the rapid expansion of the CBD market due to its increasing popularity over the last few years. CBD appears to be a substance with amazing properties that has come for good. However, this popularity is accompanied by rumors and proliferating unreliable sources of information. Let’s take a look:

1st Myth: CBD has sedative properties

In the past, CBD was thought to have sedative effects, but the truth is CBD by itself it’s actually alerting. However, sedative properties might be related to several factors such as dosage or interaction with other substances. It’s also thought to be related to the fact that some cannabis plants contain high amounts of myrcene, a potentially sedating terpene. According to research, CBD can actually mitigate THC’s sedative action. 
(However, note that CBD is used to address both anxiety and stress).

Contrary to common belief, CBD has alerting properties

2nd Myth: A small dose is sufficient

For those familiar with THC, CBD might be a softer alternative. Whether you’re a cannabis user or not, CBD has a less intense effect and oftentimes less immediate. This doesn’t mean CBD is ineffective, it just has to be consumed according to its own characteristics. Even if higher doses of CBD are used to alleviate conditions like pain, lower doses of CBD can also be beneficial, mostly when taken sublingually and for longer periods of time. 

3rd Myth: CBD is the therapeutic version of THC

CBD has been largely treated as a non-psychoactive chemical because we’re used to believe that “psychoactiveness” results in intense reactions. Strictly speaking, a psychoactive substance is one that modifies brain function, and CBD does have an effect on our brains: some treatments use CBD to modify certain brain wirings, and to positively affect mood and alertness. With this in mind, CBD can be considered psychoactive but without secondary intoxicating and/or impairing effects that other substances may cause.

CBD can be considered psychoactive but without secondary intoxicating or impairing effects that other substances may cause

4th Myth: CBD activates cannabinoid receptors

It’s a common belief that CBD works by activating cannabinoid receptors because this is the case with CBD’s close relative THC. Even though both components may have similar properties depending on its use like relieving pain, anxiety, and seizures, CBD does not work in the same way.

CBD doesn’t directly activate the CB1 and CB2 receptors in the body: it actually lowers their activity levels, counteracts THC’s effects, and also decreases endocannabinoid signaling at the CB1 receptor. 

However, CBD has kind of contradictory functions: it may also indirectly increase cannabinoid signaling. But… wasn’t it supposed to lower it? CBD is capable of having both effects because of its bidirectional functions, and you may get one or the other depending on the dosage you choose according to your needs.

You may experience different properties of CBD depending on the dosage

5th Myth: CBD is the same regardless of its origin

Even though the molecule of CBD will always be the same, its effect might vary according to its medium and interaction with other chemicals. For example, research shows that CBD enhances the beneficial therapeutic properties of THC while mitigating its possible collateral effects.

To get the most out of your CBD product of choice, it’s advisable to buy artisanal, legally registered products and to ask for detailed laboratory analysis. It’s been found that some brands include less CBD on their batches than what’s shown on their labels, so lab tests are one safe way to choose quality products.

6th Myth: CBD is legal everywhere in the States 

Along with its popularity, false information on CBD’s legal status has been spreading around. You might have heard CBD is now available virtually everywhere. The truth is that CBD is considered a member of the group of tetrahydrocannabinols and can’t be legalized until enough clinical studies have been carried out.  In any case, there’s no evidence that CBD users might suffer legal consequences for its consumption, but we highly recommend that you stay informed on the regulations of your state of residence. 


  • Russo EB. Cannabidiol claims and misconceptions. Trends Pharmacol Sci. 2017;38(3):198-201.

  • Nicholson AN, et al. Effect of delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early- morning behavior in young adults. J Clin Psychopharmacol. 2004;24:305-313.

  • Borgwardt SJ, et al. Neural basis of delta-9-tetra-hydrocannabinol and cannabidiol: effects during response inhibition. Biol Psychiatry. 2008;64:966-973.

  • Gallily R, Yekhtin Z, Hanuš LO. Overcoming the bell-shaped dose-response of cannabidiol by using cannabis extract enriched in cannabidiol. Pharmacol Pharm. 2015;6:75-85.

  • Russo E, Guy GW. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypoth. 2006;66(2):234-246.

  • Laprairie RB, et al. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br J Pharmacol. 2015;172(20):4790-4805.

  • McPartland JM, et al. Are cannabidiol and Δ9‐tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. Br J Pharmacol. 2015;172(3):737-753.

  • Leweke FM, et al. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry. 2012;2(3): e94.

  • https://www.dea.gov/divisions/hq/2015/hq122315.shtml

  • https://www.fda.gov/NewsEvents/PublicHealthFocus/ucm484109.htm